Diabetes Research · Vol. 2, No. 1 · 2016 · pp. 14–23 · e-ISSN 2379-6375

Basic Ketone Engine and Booster Glucose Engine for Energy Production

Shaw Watanabe, Azusa Hirakawa, Seiichiro Aoe, Kazunori Fukuda, Tetsuo Muneta

DOI: https://doi.org/10.17140/droj-2-125 · Published 2016-08-08 · Licence: https://creativecommons.org/licenses/by/4.0 · © 2016 The Author(s)

Abstract

Recently, hyperketonemia induced by fasting or ketogenic diet calls attention because of the possibilities for various clinical applications. Animal species comparisons and biochemical data show that all fetuses can develop by using ketogenic energy through a pathway which seems to have been maintained. We hypothesized that 3-β-hydroxybutyrate (β-HB) could be the fuel for the basic engine that produces energy in all terrestrial species. However, ATP production from glucose-pyruvic acid pathway seems to be added as a dominant system in human. We hypothesize the establishment of TCA cycle in mitochondria and enough oxygen supply since two billion years ago would be the key events to promote this change. The efficacy of ATP production from β-oxidation product is 10 ATP molecules, while it is 12.5 molecules from pyruvic acid. So, evolution should select glucose burning system as a booster engine for energy production. The liver and kidney are major ketone producing organs which contain abundant glycogen particles. So, a close relationship between ketone and glucose burning system may be present. This explains why certain level of glucose is steadily maintained even in the hyperketogenic state. Ketogenic diets efficiently treat with gestational diabetes. Placenta is the ketogenic tissue which reflects high concentration of ketones in umbilical cord blood. In addition to the role of energy source, β-HB shows various pharmacological effects on disease prevention, such as cardiovascular disease, Alzheimer’s disease, epilepsy, etc. Inhibition of histone deacetylase, stimulation of FOXO, resistance to oxidative stress, protection of mitochondria, stimulation of adiponectin release, suppression of inflammasome, etc. are included. The contribution of intestinal microbiota to ketone body production should open a new field of medicine. Altogether, the above data suggest that longer-term human studies are necessary to exclude risks of unbalanced diet and to confirm the best combination of fuels for energy production, disease prevention and medical treatment.

Keywords: Ketone β-hydroxy butyrate; TCA cycle; Histon Gestational diabetes; Fast Endocrine; Metabolism Pharmacology; Ketone; β-hydroxy butyrate; Histon; Gestational diabetes; Fast; Endocrine; Metabolism; Pharmacology

Acknowledgement

The authors appreciate Dr. Philippe Culain, MSF, for his kind English revision and discussion.

Conflicts Of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflicts of interest.

References

  1. KitabchiAEUmpierrezGEMilesJMFisherJN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009; 32(7): 1335-1343. doi: 10.2337/dc09-903210.2337/dc09-9032 https://doi.org/10.2337/dc09-9032
  2. Cahill GF Jr. Fuel metabolism in starvation. Ann Rev Nutr. 2006; 26: 1-22. doi: 10.1146/annurev.nutr.26.061505.111258 https://doi.org/10.1146/annurev.nutr.26.061505.111258
  3. Cahill GF Jr, Veechi RL. Ketoacids? Good medicine? Trans Am Clin Climatol Assoc. 2003; 114: 149-163
  4. LaffelL. Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999; 15(6): 412-426. doi: 10.1002/(SICI)1520- 7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-810.1002/(sici)1520-7560(199911/12)15:6 https://doi.org/10.1002/(sici)1520-7560(199911/12)15:6
  5. HirakawaAWatanabeSTanakaS. Koda’s fasting therapy: Energy balance and intestinal bacterial flora. Adv Food Technol Nutr Sci Open J. 2015; 1(5): 112-123. doi: 10.17140/ AFTNSOJ-1-120
  6. BlazquesCWoodsAde CeballosMLCarlingDGuzmanM. The AMP-activated protein kinase is involved in the regulation of ketone body production by astrocytes. J Neurochem. 1999; 73(4): 1674-1682. doi: 10.1046/j.1471-4159.1999.731674.x10.1046/j.1471-4159.1999.731674.x https://doi.org/10.1046/j.1471-4159.1999.731674.x
  7. KodaM. Science of the fasting therapy. Practical improvement of constitution. Osaka, Japan: Shun-ju-sha; 1980
  8. NIH, The National Institute of Diabetes and Digestive and Kidney Diseases. Gestational diabetes. 2014. Web site. https://www.niddk.nih.gov/health-information/diabetes/types/ gestational. Accessed June 28, 2016
  9. OgushiYHanakiYMunetaTDouyaHYamauchiT. Zero saccharide diet research group. Japan Society for Lipid Nutrition. 2010; 19(1): 53-58
  10. Shambaugh GE 3rd. Ketone body metabolism in the mother and fetus. Fed Proc. 1985; 44(7): 2347-2351
  11. WatanabeS. People’s physician. Angel for mothers. Muneta Maternal Clinic. Clin Funct Nutr. 2016; 8(4): 159-162
  12. KrempaskýMMaskaľováIBujňákLVajdaV. Ketone bodies in blood of dairy cows: Prevalence and monitoring of subclinical ketosis. Acta Vet Brno. 2014, 83: 411-416. doi: 10.2754/avb20148304041110.2754/avb201483040411 https://doi.org/10.2754/avb201483040411